Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung disease

References

• Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M, Bell SC, Thomson RM, Miles JJ. The rise of non-tuberculosis mycobacterial lung disease. Front Immunol. 2020;11:303. doi:10.3389/fimmu.2020.00303.
   PubMed Web of Science ®Google Scholar
• Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. Managed care health plan, 2008–2015. Ann Am Thorac Soc. 2020;17(2):178–18. doi:10.1513/AnnalsATS.201804-236OC.
   PubMed Web of Science ®Google Scholar
• Cowman S, van Ingen J, Griffith DE, Loebinger MR. Non-tuberculous mycobacterial pulmonary disease. Eur Respir J. 2019;54(1):54. doi:10.1183/13993003.00250-2019.
   Web of Science ®Google Scholar
• Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J. 2008;31(6):1322–33. doi:10.1183/09031936.00140007.
   PubMed Web of Science ®Google Scholar
• Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med. 2015;36(1):1–11. doi:10.1016/j.ccm.2014.10.001.
   PubMed Web of Science ®Google Scholar
• Marras TK, Vinnard C, Zhang Q, Hamilton K, Adjemian J, Eagle G, Zhang R, Chou E, Olivier KN. Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population. Respir Med. 2018;145:80–88. doi:10.1016/j.rmed.2018.10.022.
   PubMed Web of Science ®Google Scholar
• Shu CC, Wei YF, Chen KH, Chuang S, Wang YH, Wang CY, Wang H-C. Inhaled corticosteroids increase risk of nontuberculous mycobacterial lung disease: a nested case-control study and meta-analysis. J Infect Dis. 2021;225(4):627–36. doi:10.1093/infdis/jiab428.
   Web of Science ®Google Scholar
• Lake MA, Ambrose LR, Lipman MC, Lowe DM. ”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14:54.
   PubMed Web of Science ®Google Scholar
• Mortaz E, Moloudizargari M, Varahram M, Movassaghi M, Garssen J, Kazempour Dizagie M, Mirsaeidi M, Adcock IM. What immunological defects predispose to non-tuberculosis mycobacterial infections? Iran J Allergy Asthma Immunol. 2018;17(2):100–9.
   PubMed Web of Science ®Google Scholar
• Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3(1):4–14. doi:10.4161/gmic.19320.
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–52. doi:10.1038/nri.2016.42.
   PubMed Web of Science ®Google Scholar
• Kho ZY, Lal SK. The human gut microbiome – a potential controller of wellness and disease. Front Microbiol. 2018;9:1835. doi:10.3389/fmicb.2018.01835.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe. 2012;12(4):496–508. doi:10.1016/j.chom.2012.09.009.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Karmakar S, Babu SP. TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Braz J Infect Dis. 2016;20(2):193–204. doi:10.1016/j.bjid.2015.10.011.
   PubMed Web of Science ®Google Scholar
• Skevaki C, Pararas M, Kostelidou K, Tsakris A, Routsias JG. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol. 2015;180(2):165–177. doi:10.1111/cei.12578.
   PubMed Web of Science ®Google Scholar
• Ryu YJ, Kim EJ, Lee SH, Kim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Koh W-J. Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease. Eur Respir J. 2007;30(4):736–742. doi:10.1183/09031936.00039507.
   PubMed Web of Science ®Google Scholar
• Urban-Wojciuk Z, Khan MM, Oyler BL, Fahraeus R, Marek-Trzonkowska N, Nita-Lazar A, Hupp TR, Goodlett DR. The Role of TLRs in Anti-cancer Immunity and Tumor Rejection. Front Immunol. 2019;10:2388. doi:10.3389/fimmu.2019.02388.
   PubMed Web of Science ®Google Scholar
• Wu MF, Shu CC, Wang JY, Yan BS, Lai HC, Chiang BL, Wu LSH, Yu C-J. NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility. Sci Rep. 2019;9(1):12534. doi:10.1038/s41598-019-47609-3.
   PubMedGoogle Scholar
• Mosca A, Leclerc M, Hugot JP. Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Front Microbiol. 2016;7:455. doi:10.3389/fmicb.2016.00455.
   PubMed Web of Science ®Google Scholar
• Tang TWH, Chen HC, Chen CY, Yen CYT, Lin CJ, Prajnamitra RP, Chen L-L, Ruan S-C, Lin J-H, Lin P-J, et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation. 2019;139(5):647–659. doi:10.1161/CIRCULATIONAHA.118.035235.
   PubMed Web of Science ®Google Scholar
• Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4(1):59–72. doi:10.1016/S2213-2600(15)00427-0.
   PubMed Web of Science ®Google Scholar
• Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18(1):2. doi:10.1186/s12865-016-0187-3.
   PubMed Web of Science ®Google Scholar
• Ruff WE, Greiling TM, Kriegel MA. Host–microbiota interactions in immune-mediated diseases. Nat Rev Microbiol. 2020;18(9):521–538. doi:10.1038/s41579-020-0367-2.
   PubMed Web of Science ®Google Scholar
• Ahlawat S, Asha, Sharma KK. Gut–organ axis: a microbial outreach and networking. Lett Appl Microbiol. 2021;72(6):636–668. doi:10.1111/lam.13333.
   PubMed Web of Science ®Google Scholar
• Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492–506. doi:10.1038/s41422-020-0332-7.
   PubMed Web of Science ®Google Scholar
• Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012;5(1):7–18. doi:10.1038/mi.2011.55.
   PubMed Web of Science ®Google Scholar
• Budden KF, Gellatly SL, Wood DL, Cooper MA, Morrison M, Hugenholtz P, Hansbro PM. Emerging pathogenic links between microbiota and the gut–lung axis. Nat Rev Microbiol. 2017;15(1):55–63. doi:10.1038/nrmicro.2016.142.
   PubMed Web of Science ®Google Scholar
• He Y, Wen Q, Yao F, Xu D, Huang Y, Wang J. Gut–lung axis: The microbial contributions and clinical implications. Crit Rev Microbiol. 2017;43(1):81–95. doi:10.1080/1040841X.2016.1176988.
   PubMed Web of Science ®Google Scholar
• Openshaw PJ. Crossing barriers: infections of the lung and the gut. Mucosal Immunol. 2009;2(2):100–2. doi:10.1038/mi.2008.79.
   PubMed Web of Science ®Google Scholar
• Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, Picu A, Petcu L, Chifiriuc MC. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 2018;9:1830. doi:10.3389/fimmu.2018.01830.
   PubMed Web of Science ®Google Scholar
• Rosenow EC 3rd, Wilson WR, Cockerill FR 3rd. Pulmonary disease in the immunocompromised host. 1. Mayo Clin Proc. 1985;60(7):473–487. doi:10.1016/S0025-6196(12)60872-6.
   PubMed Web of Science ®Google Scholar
• Fagundes CT, Amaral FA, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, Teixeira MM, Souza DG. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J Immunol. 2012;188(3):1411–1420. doi:10.4049/jimmunol.1101682.
   PubMed Web of Science ®Google Scholar
• Felix KM, Jaimez IA, Nguyen TV, Ma H, Raslan WA, Klinger CN, Doyle KP, Wu HJJ. Gut microbiota contributes to resistance against pneumococcal pneumonia in immunodeficient rag−/− mice. Front Cell Infect Microbiol. 2018;8:118. doi:10.3389/fcimb.2018.00118.
   PubMed Web of Science ®Google Scholar
• Groves HT, Higham SL, Moffatt MF, Cox MJ, Tregoning JS, Bomberger JM. Respiratory viral infection alters the gut microbiota by inducing inappetence. mBio. 2020;11(1):11. doi:10.1128/mBio.03236-19.
   Web of Science ®Google Scholar
• Negi S, Pahari S, Bashir H, Agrewala JN. Gut microbiota regulates mincle mediated activation of lung dendritic cells to protect against mycobacterium tuberculosis. Front Immunol. 2019;10:1142. doi:10.3389/fimmu.2019.01142.
   PubMed Web of Science ®Google Scholar
• Ito T, Carson W, Cavassani KA, Connett JM, Kunkel SL. CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res. 2011;317:613–9. doi:10.1016/j.yexcr.2010.12.018.
   PubMed Web of Science ®Google Scholar
• Luxameechanporn T, Kirtsreesakul V, Klemens J, Khoury P, Thompson K, Naclerio RM. Evaluation of importance of Toll-like receptor 4 in acute Streptococcus pneumoniae sinusitis in mice. Arch Otolaryngol Head Neck Surg. 2005;131(11):1001–06. doi:10.1001/archotol.131.11.1001.
   PubMedGoogle Scholar
• Deng JC, Moore TA, Newstead MW, Zeng X, Krieg AM, Standiford TJ. CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J Immunol. 2004;173(8):5148–55. doi:10.4049/jimmunol.173.8.5148.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST.
   PubMed Web of Science ®Google Scholar
• Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, Ojcius DM, Lu C-C, Young JD, Lai H-C. et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 2019;68(2):248–262. doi:10.1136/gutjnl-2017-315458.
   PubMed Web of Science ®Google Scholar
• Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng S-F, Wu T-R, Chen YYM, Young JD. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2015;6(1):7489. doi:10.1038/ncomms8489.
   PubMedGoogle Scholar
• Chang CJ, Lu CC, Lin CS, Martel J, Ko YF, Ojcius DM, Wu T-R, Tsai Y-H, Yeh T-S, Lu J-J. et al. Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice. Int J Obes (Lond). 2018;42(2):231–243. doi:10.1038/ijo.2017.149.
   PubMed Web of Science ®Google Scholar
• Paulson JN, Stine OC, Bravo HC, Pop M. Differential abundance analysis for microbial marker-gene surveys. Nat Methods. 2013;10(12):1200–02. doi:10.1038/nmeth.2658.
   PubMed Web of Science ®Google Scholar
• Gray L, Hasebe K, O’Hely M, Ponsonby AL, Vuillermin P, Collier F, BIS Investigator Group. Rapid PCR identification of Prevotella copri in an Australian cohort of pregnant women. J Dev Orig Health Dis. 2020;11(3):228–234. doi:10.1017/S2040174419000849.
   PubMed Web of Science ®Google Scholar
• Lai HC, Chang CJ, Lin CS, Wu TR, Hsu YJ, Wu TS, Lu J-J, Martel J, Ojcius DM, Ku C-L. et al. NK cell–derived IFN-γ protects against nontuberculous mycobacterial lung infection. J Immunol. 2018;201(5):1478–90. doi:10.4049/jimmunol.1800123.
   PubMed Web of Science ®Google Scholar
• Mistry P, Laird MH, Schwarz RS, Greene S, Dyson T, Snyder GA, Xiao TS, Chauhan J, Fletcher S, Toshchakov VY. et al. Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain. Proc Natl Acad Sci USA. 2015;112(17):5455–60. doi:10.1073/pnas.1422576112.
   PubMed Web of Science ®Google Scholar
• Deng Y, Liu K, Pan Y, Ren J, Shang J, Chen L, Liu H. TLR2 antagonism attenuates the hippocampal neuronal damage in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress. Sleep Breath. 2020;24(4):1613–21. doi:10.1007/s11325-020-02030-3.
   PubMed Web of Science ®Google Scholar
• De Castro C, Parrilli M, Holst O, Molinaro A. Microbe-associated molecular patterns in innate immunity: Extraction and chemical analysis of gram-negative bacterial lipopolysaccharides. Methods Enzymol. 2010;480:89–115.
   PubMed Web of Science ®Google Scholar
• Prasoodanan PKV, Sharma AK, Mahajan S, Dhakan DB, Maji A, Scaria J, Sharma VK. Western and non-western gut microbiomes reveal new roles of Prevotella in carbohydrate metabolism and mouth–gut axis. Npj Biofilms Microbiomes. 2021;7(1):77. doi:10.1038/s41522-021-00248-x.
   PubMed Web of Science ®Google Scholar
• Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D, Tzianabos AO, Kasper DL. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med. 2006;203(13):2853–63. doi:10.1084/jem.20062008.
   PubMed Web of Science ®Google Scholar
• Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011;332(6032):974–977. doi:10.1126/science.1206095.
   PubMed Web of Science ®Google Scholar
• Kayama H, Takeda K. Polysaccharide a of Bacteroides fragilis: actions on dendritic cells and T cells. Mol Cell. 2014;54(2):206–7. doi:10.1016/j.molcel.2014.04.002.
   PubMed Web of Science ®Google Scholar
• Vankayalapati R, Wizel B, Samten B, Griffith DE, Shams H, Galland MR, Fordham von Reyn C, Girard WJ, Wallace R Jr., Barnes P. et al. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis. 2001;183(3):478–484. doi:10.1086/318087.
   PubMed Web of Science ®Google Scholar
• Lim A, Allison C, Price P, Waterer G. Susceptibility to pulmonary disease due to Mycobacterium avium–intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency. Clin Immunol. 2010;137(2):296–302. doi:10.1016/j.clim.2010.07.011.
   PubMed Web of Science ®Google Scholar
• Kim SY, Koh WJ, Park HY, Jeon K, Kwon OJ, Cho SN, Shin SJ. Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease. Clin Exp Immunol. 2014;176(1):93–101. doi:10.1111/cei.12253.
   PubMed Web of Science ®Google Scholar
• Shu CC, Wang JY, Wu MF, Wu CT, Lai HC, Lee LN, Chiang B-L, Yu C-J. Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes. Sci Rep. 2017;7(1):42004. doi:10.1038/srep42004.
   PubMedGoogle Scholar
• Lee MR, Chang LY, Ko JC, Wang HC, Huang YW. Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review. J Formos Med Assoc. 2020;119 Suppl 1:S4–S12. doi:10.1016/j.jfma.2020.05.019.
   PubMed Web of Science ®Google Scholar
• Lore NI, Yamasaki S, Simmonds RE, Jo EK. Editorial: Host-pathogen interactions in nontuberculous mycobacterial infections. Front Immunol. 2023;14:1201159. doi:10.3389/fimmu.2023.1201159.
   PubMed Web of Science ®Google Scholar
• Andrejak C, Almeida DV, Tyagi S, Converse PJ, Ammerman NC, Grosset JH. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations. Antimicrob Agents Chemother. 2015;59(4):2129–35. doi:10.1128/AAC.04841-14.
   PubMed Web of Science ®Google Scholar
• Schuijt TJ, Lankelma JM, Scicluna BP, de Sousae Melo F, Roelofs JJ, de Boer JD, Hoogendijk AJ, de Beer R, de Vos A, Belzer C. et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016;65(4):575–583. doi:10.1136/gutjnl-2015-309728.
   PubMed Web of Science ®Google Scholar
• Huang Y, Tang J, Cai Z, Zhou K, Chang L, Bai Y, Ma Y. Prevotella induces the production of Th17 cells in the colon of mice. J Immunol Res. 2020;2020:1–14. doi:10.1155/2020/9607328.
   Web of Science ®Google Scholar
• Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151(4):363–374. doi:10.1111/imm.12760.
   PubMed Web of Science ®Google Scholar
• Leite AZ, Rodrigues NC, Gonzaga MI, Paiolo JCC, de Souza CA, Stefanutto NAV, Omori WP, Pinheiro DG, Brisotti JL, Matheucci Junior E. et al. Detection of increased plasma Interleukin-6 levels and prevalence of prevotella copri and bacteroides vulgatus in the Feces of type 2 diabetes patients. Front Immunol. 2017;8:1107. doi:10.3389/fimmu.2017.01107.
   PubMed Web of Science ®Google Scholar
• Nish S, Medzhitov R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity. 2011;34(5):629–636. doi:10.1016/j.immuni.2011.05.009.
   PubMed Web of Science ®Google Scholar
• Underhill DM. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol Rev. 2007;219(1):75–87. doi:10.1111/j.1600-065X.2007.00548.x.
   PubMedGoogle Scholar
• Iljazovic A, Amend L, Galvez EJC, de Oliveira R, Strowig T. Modulation of inflammatory responses by gastrointestinal Prevotella spp. – from associations to functional studies. Int J Med Microbiol. 2021;311(2):151472. doi:10.1016/j.ijmm.2021.151472.
   PubMed Web of Science ®Google Scholar
• Wang Y, Telesford KM, Ochoa-Reparaz J, Haque-Begum S, Christy M, Kasper EJ, Wang L, Wu Y, Robson SC, Kasper DL. et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun. 2014;5(1):4432. doi:10.1038/ncomms5432.
   PubMedGoogle Scholar
• Pfeiffer S, Jatzlauk G, Lund JV, Boateng E, Kovacevic D, Nh M, Bartel S, Schloter M, Krauss‐Etschmann S. Oral application of vancomycin alters murine lung microbiome and pulmonary immune responses. Immun Inflam Dis. 2022;10(8):e675. doi:10.1002/iid3.675.
   PubMed Web of Science ®Google Scholar
• Le Noci V, Guglielmetti S, Arioli S, Camisaschi C, Bianchi F, Sommariva M, Storti C, Triulzi T, Castelli C, Balsari A. et al. Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: a strategy to promote immunosurveillance against lung metastases. Cell Rep. 2018;24(13):3528–38. doi:10.1016/j.celrep.2018.08.090.
   PubMed Web of Science ®Google Scholar